Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MultiCell Technologies Inc.
DescriptionHigh molecular weight synthetic dsRNA with immune enhancing properties mediated by toll-like receptor 3 (TLR3), TLR7, TLR8, interferon induced with helicase C domain 1 (IFIH1; MDA5) and DEAD box polypeptide 58 (DDX58; RIG-I)
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today